tAnGo: A randomized phase III trial of gemcitabine (gem) in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy (CT) for women with early-stage breast cancer (EBC). - Poole,C.J.; Hiller,L.; Howard,H.C.; Dunn,J.A.; Canney,P.; Wardley,A.M.; Kennedy,M.J.; Coleman,R.E.; Leonard,R.C.; Earl,H.M. (J Clin Oncol, 2008)